Adult patient with type 1 diabetes mellitus: Multiple factors to achieve an adequate control. Case report
DOI:
https://doi.org/10.24265/horizmed.2020.v20n4.14Keywords:
Diabetes mellitus type 1, Treatment adherence and compliance, Blood glucose self-monitoringAbstract
Type 1 diabetes mellitus (T1DM) is one of the most common chronic childhood diseases. However, a large number of adult patients live with this condition. Insulin therapy is the cornerstone of diabetes treatment. Other important aspects are the promotion of a healthy lifestyle and the adhesion to medications. This is the case of a 29-year-old woman with a fifteenyear diagnosis of T1DM. Medical treatment and evolution over the last five years are described. The importance of new technologies such as continuous glucose monitoring and other factors such as adherence to treatment and family support were particularly important for the patient’s adequate disease control.
Downloads
References
Atkinson MA, Eisenbarth GS, Michels AW. Type 1 diabetes. Lancet. 2014; 383(9911): 69-82.
Jaser SS. Family interaction in pediatric diabetes. Curr Diab Rep. 2011; 11(6): 480–5.
Freeborn D, Dyches T, Roper SO. Lessons Learned from a life with type 1 diabetes: adult perspectives. Diabetes Spectr. 2017; 30(3): 188-94.
Dhaliwal R, Weinstock RS. Management of type 1 diabetes in older adults. Diabetes Spectr. 2014; 27(1): 9–20.
Cho NH, Shaw JE, Karuranga S, Huang Y, da Roche Fernandes JD, Ohlrogge AW, et al. IDF diabetes atlas: global estimates of diabetes prevalence for 2017 and projections for 2045. Diabetes Res Clin Pract. 2018; 138: 271-81.
Karvonen M, Viik-Kajander M, Moltchanova E, Libman I, Laporte R, Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. 2000; 23(10): 1516-26.
Seclén S, Rojas MI. Diabetes Mellitus Tipo 1 en población infantil peruana. Diagnóstico. 2002; 41(2): 54-62.
Lind M, Svensson A-M, Rosengren A. Glycemic control and excess mortality in type 1 diabetes. N Engl J Med. 2015; 372(9): 880-1.
American Diabetes Association. Standards of Medical Care in Diabetes-2018. Abridged for Primary Care Providers. Clin Diabetes. 2018; 36(1): 14-37.
Palmezano-Díaz JM, Figueroa-Pineda CL, Rodríguez R, Plazas-Rey L, Corredor-Guzmán K, Pradilla-Suárez LP, et al. Características clínicas y sociodemográficas de pacientes con diabetes tipo 1 en un Hospital Universitario de Colombia. Med Int Méx. 2018; 34(1): 46-56.
Bzowyckyj A. Updates and advances in technology for diabetes selfmanagement. Pharmacy Today. 2019; 25(5): 43-58.
Foster NC, Beck RW, Miller KM, Clements MA, Rickels MR, DiMeglio LA, et al. State of type 1 diabetes management and outcomes from the T1D exchange in 2016–2018. Diabetes Technol Ther. 2019; 21(2): 66–72.
Hortensius J, Kars MC, Wierenga WS, Kleefstra N, Bilo HJ, van der Bijl JJ. Perspectives of patients with type 1 or insulin-treated type 2 diabetes on self-monitoring of blood glucose: a qualitative study. BMC Public Health. 2012; 12(1): 167.
NICE Guideline 18 [NG18]. Diabetes (type 1 and type 2) in children and young people: diagnosis and management. Methods, evidence and recommendations. 2016.
Vehik K, Dabelea D. The changing epidemiology of type 1 diabetes: why is it going through the roof?. Diabetes Metab Res Rev. 2011; 27(1): 3-13.
Katz M, Laffel L. Mortality in type 1 diabetes in the current era: two steps forward, one step backward. JAMA. 2015; 313(1): 35-6.
Lind M, Pivodic A, Svensson A-M, Ólafsdóttir AF, Wedel H, Ludvigsson J. HbA 1c level as a risk factor for retinopathy and nephropathy in children and adults with type 1 diabetes: Swedish population based cohort study. BMJ. 2019; 366: 14894.
Chiang JL, Maahs DM, Garvey KC, Hood KK, Laffel LM, Weinzimer SA, et al. Type 1 diabetes in children and adolescents: a position statement by the American Diabetes Association. Diabetes Care. 2018; 41(9): 2026-44
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group, Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008; 359(14): 1464-76
Evans M, Welsh Z, Ells S, Seibold A. The impact of flash glucose monitoring on glycaemic control as measured by HbA1c: a metaanalysis of clinical trials and real-world observational studies. Diabetes Ther. 2020; 11(1): 83-95.
Turton JL, Raab R, Rooney KB. Low-carbohydrate diets for type 1 diabetes mellitus: a systematic review. PLoS One. 2018; 13(3): e0194987.
Quirk H, Blake H, Tennyson R, Randell TL, Glazebrook C. Systematic review or meta-analysis physical activity interventions in children and young people with type 1 diabetes mellitus: a systematic review with meta-analysis. Diabet Med. 2014; 31(1): 1163-73.
Goethals ER, Oris L, Soenens B, Berg CA, Prikken S, Broeck NV, et al. Parenting and treatment adherence in type 1 diabetes throughout adolescence and emerging adulthood. J Pediatr Psychol. 2017; 42(9): 922–32.
Henríquez-Tejo R, Cartes-Velásquez R. Psychosocial impact of type 1 diabetes mellitus in children, adolescents and their families. Literature review. Rev Chil Pediatr. 2018; 89(3): 391-8.
Lesley Lowes, Eddy D, Channon S, McNamara R, Robling M, Gregory JW, et al. The experience of living with type 1 diabetes and attending clinic from the perception of children, adolescents and carers: analysis of qualitative data from the DEPICTED study. J Pediatr Nurs. 2015; 30(1): 54-62.
Goethals ER, de Wit M, Van Broeck N, Lemiere J, Van Liefferinge D, Bohler S, et al. Child and parental executive functioning in type 1 diabetes: Their unique and interactive role toward treatment adherence and glycemic control. Pediatr Diabetes. 2018; 19(3): 520-6.
Beck RW, Bergenstal RM, Laffel LM, Pickup JC. Advances in technology for management of type 1 diabetes. Lancet. 2019; 394(10205): 1265-73.
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 Horizonte Médico (Lima)
This work is licensed under a Creative Commons Attribution 4.0 International License.
Horizonte Médico (Lima) (Horiz. Med.) journal’s research outputs are published free of charge and are freely available to download under the open access model, aimed at disseminating works and experiences developed in biomedical and public health areas, both nationally and internationally, and promoting research in the different fields of human medicine. All manuscripts accepted and published in the journal are distributed free of charge under the terms of a Creative Commons license – Attribution 4.0 International (CC BY 4.0).
